Frederick Herman Hausheer, M.D., F.A.C.P.

Frederick Herman Hausheer, M.D., F.A.C.P. is an oncology and pharmaceutical research expert specializing in the development and regulation of novel cancer therapeutics. With a career spanning executive leadership in global pharmaceutical research and development, he brings a strategic perspective to litigation involving drug development and compliance. His work centers on investigating patent validity, assessing regulatory compliance, and evaluating whether industry standards in oncology drug development have been met.

Dr. Hausheer has been retained in numerous expert witness and consulting engagements across the United States, involving pharmaceutical research, oncology drug development, and regulatory compliance. His M.D. from the University of Missouri-Columbia, along with certifications such as Designated Clinical Investigator by the National Cancer Institute, reinforce his ability to deliver objective, defensible analyses. He is regularly engaged by both plaintiff and defense counsel to provide clear, independent determinations of causation in disputes involving pharmaceutical regulation and oncology therapeutics.